US 11773103
IRAK4 degraders and uses thereof
granted A61KA61K31/519A61K31/5375
Quick answer
US patent 11773103 (IRAK4 degraders and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/519, A61K31/5375, A61P, A61P29/00